Industry-leading mAb discovery using human transgenic mouse technologies.


Over 60 global pharmaceutical companies, large and small, rely on Abveris to develop therapeutic antibody candidates.

Our Boston-based team of discovery scientists is composed of experienced biotherapeutic drug discovery scientists with a passion for novel antibody discovery.  We use advanced immunization techniques, engineered in vivo systems, optimized antibody capture methods, robust high-throughput screening technologies, and diverse ancillary capabilities to deliver excellent therapeutic leads with critical timelines in mind.


  • Our team is experienced in biologic drug discovery with a variety of humanized mice. This experience is important when our clients are relying on us to deliver the next generation of biologics against increasingly difficult targets
  • A big toolbox enables us to tackle a diverse set of challenges
    • Antigen and screening materials development
    • Multiple immunization techniques including: DNA immunization, cell immunization, rapid protocols, adjuvants to break tolerance and assist in cross-reactivity and more
    • Highly efficient B cell screening and hybridoma approaches
    • High-throughput, industry-leading screening tools to identify ideal mAbs including the iQue flow cytometer along with the Octet and Carterra systems for affinity, activity and epitope binning analysis.
    • In-house sequencing capabilities
  • All work performed in our Boston Area location
  • Expert project management with a thoughtful and collaborative communication style



The Trianni Mouse


Harbour Biomed Logo

The Harbor H2L2 Mouse



Get in touch with our scientists to discuss your project!

We like to meet in person with our Boston clients. We can setup a Zoom to connect if you're further away.